Successful treatment of a patient with advanced lung adenocarcinoma (EGFR-T790M and C797S cis) with lazertinib: A case report and literature review

Lazertinib has been shown to treat non-small cell lung cancer (NSCLC) patients with EGFR-T790M, Ex19del, and L858R mutations. However, there are still no studies to prove that lazertinib could be used in patients with EGFR-T790M and C797s cis mutations in NSCLC. We report a case of a patient with ad...

Descripción completa

Detalles Bibliográficos
Autores principales: Fang, Yue, Zhang, Qiankun, Wang, Weimin, Tong, Juanjuan, Li, Xialin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9868826/
https://www.ncbi.nlm.nih.gov/pubmed/36698414
http://dx.doi.org/10.3389/fonc.2022.1037964

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9868826/
https://www.ncbi.nlm.nih.gov/pubmed/36698414
http://dx.doi.org/10.3389/fonc.2022.1037964

Ejemplares similares